Caroline Piatek, MD | Authors

Thrombocytopenia: Optimizing Approaches in Cancer Patients

April 15, 2015

Chemotherapy-induced thrombocytopenia causes nearly two-thirds of cases of thrombocytopenia in the cancer setting. In patients receiving chemotherapy, thrombocytopenia leads to dose reductions in 15% of treatment cycles and chemotherapy delays in 6% of cycles.